Neurostar RTMS denied as not medically necessary by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for neurostar rtms are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UHC Denied NeuroStar TMS as Not Medically Necessary — and How to Appeal

NeuroStar TMS (transcranial magnetic stimulation) is an FDA-cleared neurostimulation treatment for major depressive disorder and certain other psychiatric diagnoses. A medical-necessity denial from UnitedHealthcare means a UHC clinical reviewer determined that the submitted documentation did not satisfy all elements of UHC's coverage criteria for TMS — most often because the record did not adequately document the required diagnosis, symptom severity, or prior treatment failures.

### Why This Denial Is Appealable

Medical necessity is a clinical judgment, not a purely administrative one. When a qualified psychiatrist has determined that TMS is necessary for your care, UHC cannot simply override that judgment without a clinical basis. Under ERISA Section 503 and ACA Section 2719, you are entitled to a full-and-fair review conducted by a clinical professional in the relevant specialty. If UHC's internal review is adverse, you may escalate to an independent external reviewer — whose decision is binding on UHC.

### Your Appeal Timeline

• Internal appeal: File by the deadline on your denial letter. UHC must decide pre-service appeals within 30 days; post-service within 60 days.
• External review: Generally available within four months of an adverse internal decision. The external reviewer's decision is binding.
• Expedited review: If your condition is urgent, request expedited processing; decisions are required within 72 hours.

### Documentation to Gather

1. Diagnosis confirmation — complete psychiatric evaluation notes documenting the diagnosis (e.g., major depressive disorder) and current episode severity using a validated, chart-documented scale. 2. Functional impairment documentation — records showing how your condition affects work, relationships, self-care, or safety, establishing the clinical impact that makes treatment necessary now. 3. Prior-treatment history with outcomes — a dated, itemized list of every antidepressant medication (and any other treatment) you have tried, including duration, doses used, and the clinical reason each was stopped or considered inadequate. This is typically the most scrutinized element of UHC's TMS criteria. 4. Prescriber medical-necessity letter — a detailed letter from your treating psychiatrist explaining your diagnosis, the severity of your illness, each prior failed treatment, and the specific clinical rationale for TMS. The letter should address each element of UHC's published TMS coverage policy by name.

### Criteria-Mapping Structure

Request UHC's current coverage policy for TMS (NeuroStar or equivalent). Also review the FDA-approved labeling for NeuroStar. Build a side-by-side table: in the left column, copy each coverage requirement verbatim from UHC's policy; in the right column, cite the exact chart note, date, or clinical finding that satisfies it. Attach the supporting document as a labeled exhibit for each row. Include references to applicable national psychiatric guideline organization recommendations (e.g., from the APA or relevant society) supporting TMS for your specific presentation. This structured format directly addresses the reviewer's checklist and is far more persuasive than a narrative-only appeal letter.